Clinical Trial Update: Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating combination chemotherapy with filgrastim, with or without rituximab, in older patients with Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Neupogen (Filgrastim)
• Rituximab (rituximab)

Snippet

Sponsor: Commissie Voor Klinisch Toegepast Onderzoek | Conditions: Lymphoma | Phase 3 | Status: UNKNOWN